“…Fifty‐seven studies assessing injections in major joints were identified (see online supplementary Appendix 1) [5‐61]. A majority of the studies (49/57 [86%]) [6,7,9,11‐13,15,17‐25,27‐30,32‐51,53‐61] evaluated injections in a single joint, whereas 14% (8/57) [5,8,10,16,26,31,52,55] assessed injections in more than one joint. Thirty‐five percent (20/57) of the studies evaluated knee injections [8‐10,13,15,16,19‐23,26,31,32,36,37,48,52,56,57], 46% (26/57) evaluated glenohumeral (GH) joint injections [5,7,8,10,11,15‐17,24‐26,28,29,31,38‐40,42,43,46,47,49,52,54,60,61], 21% (12/57) evaluated hip injections [8,12,27,30,33,35,41,44,45,50,52,59,62], and 4% (2/57) evaluated sacroiliac (SI) joint injections [18,34].…”